AU6745700A - 49 human secreted proteins - Google Patents
49 human secreted proteinsInfo
- Publication number
- AU6745700A AU6745700A AU67457/00A AU6745700A AU6745700A AU 6745700 A AU6745700 A AU 6745700A AU 67457/00 A AU67457/00 A AU 67457/00A AU 6745700 A AU6745700 A AU 6745700A AU 6745700 A AU6745700 A AU 6745700A
- Authority
- AU
- Australia
- Prior art keywords
- secreted proteins
- human secreted
- human
- proteins
- secreted
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Hematology (AREA)
- Zoology (AREA)
- Cardiology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Diabetes (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Dermatology (AREA)
- Toxicology (AREA)
- Heart & Thoracic Surgery (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US12660199P | 1999-03-26 | 1999-03-26 | |
US60126601 | 1999-03-26 | ||
US15437399P | 1999-09-17 | 1999-09-17 | |
US60154373 | 1999-09-17 | ||
US17606400P | 2000-01-14 | 2000-01-14 | |
US60176064 | 2000-01-14 | ||
PCT/US2000/007677 WO2000063230A2 (fr) | 1999-03-26 | 2000-03-23 | 49 proteines secretees humaines |
Publications (1)
Publication Number | Publication Date |
---|---|
AU6745700A true AU6745700A (en) | 2000-11-02 |
Family
ID=27383444
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU67457/00A Abandoned AU6745700A (en) | 1999-03-26 | 2000-03-23 | 49 human secreted proteins |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP1171462A2 (fr) |
JP (1) | JP2002541833A (fr) |
AU (1) | AU6745700A (fr) |
CA (1) | CA2364209A1 (fr) |
WO (1) | WO2000063230A2 (fr) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6573095B1 (en) * | 1998-04-29 | 2003-06-03 | Genesis Research & Development Corporation Limited | Polynucleotides isolated from skin cells |
EP1254246A4 (fr) * | 2000-01-25 | 2003-05-21 | Hyseq Inc | Methodes et matieres concernant des polypeptides et polynucleotides similaires a alpha de facteur de croissance de transformation |
AU2001260847A1 (en) * | 2000-05-24 | 2001-12-03 | Genesis Research And Development Corporation Limited | Compositions isolated from skin cells and methods for their use |
WO2002097030A2 (fr) | 2001-05-25 | 2002-12-05 | Nymox Corporation | Peptides efficaces dans le traitement de tumeurs et d'autres maladies necessitant le retrait ou la destruction de cellules |
EP1847550A3 (fr) * | 2001-07-19 | 2008-01-09 | Nymox Corporation | Peptides actives dans le traitement des tumeurs et autre conditions requérant la suppression ou la destruction de cellules |
BRPI0211200B8 (pt) | 2001-07-19 | 2021-07-27 | Nymox Corp | peptídeos efetivos no tratamento de tumores e outras condições que requerem a remoção ou destruição de células |
US7317077B2 (en) | 2001-11-16 | 2008-01-08 | Nymox Pharmaceutical Corporation | Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
KR100535543B1 (ko) * | 2002-09-13 | 2005-12-08 | 현대자동차주식회사 | 스로틀 밸브 동결 방지장치 |
US11628202B2 (en) | 2015-07-24 | 2023-04-18 | Nymox Corporation | Methods of reducing the need for surgery in patients suffering from benign prostatic hyperplasia |
US10183058B2 (en) | 2016-06-17 | 2019-01-22 | Nymox Corporation | Method of preventing or reducing the progression of prostate cancer |
US10172910B2 (en) | 2016-07-28 | 2019-01-08 | Nymox Corporation | Method of preventing or reducing the incidence of acute urinary retention |
US10532081B2 (en) | 2016-09-07 | 2020-01-14 | Nymox Corporation | Method of ameliorating or preventing the worsening or the progression of symptoms of BPH |
US10335453B2 (en) | 2017-03-01 | 2019-07-02 | Nymox Corporation | Compositions and methods for improving sexual function |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5457038A (en) * | 1988-11-10 | 1995-10-10 | Genetics Institute, Inc. | Natural killer stimulatory factor |
-
2000
- 2000-03-23 EP EP00955227A patent/EP1171462A2/fr not_active Withdrawn
- 2000-03-23 JP JP2000612320A patent/JP2002541833A/ja not_active Withdrawn
- 2000-03-23 AU AU67457/00A patent/AU6745700A/en not_active Abandoned
- 2000-03-23 CA CA002364209A patent/CA2364209A1/fr not_active Abandoned
- 2000-03-23 WO PCT/US2000/007677 patent/WO2000063230A2/fr not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
WO2000063230A2 (fr) | 2000-10-26 |
CA2364209A1 (fr) | 2000-10-26 |
JP2002541833A (ja) | 2002-12-10 |
EP1171462A2 (fr) | 2002-01-16 |
WO2000063230A3 (fr) | 2001-02-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU1473501A (en) | 21 human secreted proteins | |
AU1438001A (en) | 27 human secreted proteins | |
AU1604401A (en) | 18 human secreted proteins | |
AU1448701A (en) | 15 human secreted proteins | |
AU1334101A (en) | 19 human secreted proteins | |
AU3769700A (en) | 45 human secreted proteins | |
AU2757500A (en) | 33 human secreted proteins | |
AU6745700A (en) | 49 human secreted proteins | |
AU1918601A (en) | 23 human secreted proteins | |
AU3517000A (en) | 50 human secreted proteins | |
AU3628600A (en) | 46 human secreted proteins | |
AU1916101A (en) | 19 human secreted proteins | |
AU1342501A (en) | 32 human secreted proteins | |
AU3765500A (en) | 50 human secreted proteins | |
AU3208700A (en) | 33 human secreted proteins | |
AU3249300A (en) | 47 human secreted proteins | |
AU1449001A (en) | 28 human secreted proteins | |
AU1472801A (en) | 24 human secreted proteins | |
AU3767300A (en) | 47 human secreted proteins | |
AU3766800A (en) | 48 human secreted proteins | |
AU3871300A (en) | 50 human secreted proteins | |
AU3628700A (en) | 49 human secreted proteins | |
AU3730500A (en) | 50 human secreted proteins | |
AU3529000A (en) | 47 human secreted proteins | |
AU1438201A (en) | 25 human secreted proteins |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |